Managing complex arteriovenous malformations represents one of the most demanding challenges in contemporary neurosurgery. Clinicians frequently combine endovascular intervention with microsurgical resection to achieve complete obliteration. Recently, single-stage AVM surgery performed within hybrid operating suites has emerged as a compelling paradigm. By conducting embolisation and microsurgery in an unbroken workflow, surgical teams mitigate the hemorrhage risks inherent to staged interventions. However, adopting this multimodality protocol demands high technical proficiency and institutional coordination. A nationwide multicentre prospective registry study has now illuminated the learning curve and strategic shifts that define reproducible clinical success.

The Clinical Value of Single-Stage AVM Surgery

Complex cerebral vascular malformations carry substantial risks of intracranial hemorrhage, neurological disability, and intractable seizures. Historically, multimodal treatment relied on multistage embolisation sessions spaced weeks apart prior to resection. Nevertheless, this staged approach creates vulnerable intervals where altered hemodynamics can trigger catastrophic nidus rupture. In contrast, single-stage AVM surgery consolidates endovascular devascularization and microsurgical excision under a single anesthetic event. Consequently, neurosurgeons eliminate interval hemorrhagic risk while maximizing hemodynamic stability. Furthermore, immediate access to intraoperative angiography provides real-time verification of total lesion eradication before closure. Despite these technical advantages, dual procedural demands generate an intricate workflow. Teams must master catheter navigation alongside microsurgical parenchymal dissection. Therefore, understanding the trajectory of technical mastery is essential for centers seeking to implement hybrid neurovascular protocols safely.

Evidence from the Nationwide Multicentre MATCH Registry

To delineate institutional performance benchmarks, investigators evaluated data from the Multimodality Treatment for Brain Arteriovenous Malformations (MATCH) registry in China. This prospective study tracked 213 patients with complex lesions treated between August 2011 and December 2023. Researchers divided the cohort chronologically into two sequential phases to analyze temporal performance trends. Group 1 comprised the initial 25 treated patients, representing early procedural adoption. Meanwhile, Group 2 included the subsequent 188 consecutive cases managed with refined operational experience. Through cumulative summation analysis, investigators measured major complications, neurological deterioration, and modified Rankin Scale changes. Importantly, procedural safety improved markedly across time. Major surgical complications declined from 52.00% in Group 1 to 34.57% in Group 2. In addition, unfavorable functional outcomes dropped from 44.00% to 18.62%. These findings confirm that institutional experience directly enhances patient safety profiles.

Quantifying the Learning Curve and Operative Proficiency

Mastering complex cerebrovascular hybrid interventions requires navigating a demanding operational learning curve. According to cumulative summation analysis, surgical teams must complete approximately 25 complex cases to achieve procedural reproducibility. Moreover, statistical analyses demonstrated an inflection point where complication rates stabilized significantly after 50 lifetime cases. Multivariable regression confirmed that surgeon experience served as an independent protective factor against poor neurological outcomes. Specifically, accumulated operative volume reduced the odds of unfavorable functional outcomes by nearly two-thirds. Early in the surgical series, operators faced prolonged operative durations, excessive blood loss, and unintended venous occlusion. Conversely, experienced operators demonstrated superior tissue handling, refined microvascular clipping, and sharper spatial awareness around eloquent anatomy. As a result, catastrophic perioperative morbidity diminished sharply as surgical volume increased. Surgical departments must therefore anticipate this 25-case threshold when credentialing teams for independent hybrid interventions.

Strategic Evolution in Preoperative Embolisation Strategies

The study highlighted a profound philosophical pivot regarding preoperative endovascular intent during single-stage AVM surgery. Initially, interventionists prioritized aggressive curative embolisation, attempting to eliminate substantial nidus volume. Consequently, curative embolisation accounted for 72.00% of cases in Group 1, but this aggressive approach frequently induced dangerous intranidal pressure shifts. In contrast, the protocol shifted toward palliative and targeted embolisation in Group 2, rising to 67.55% and 13.30% respectively. Rather than attempting complete endovascular occlusion, modern hybrid protocols utilize targeted embolisation to seal deep feeding arteries, secure aneurysms, and reduce high-flow fistulas. Meanwhile, interventionists carefully preserve primary venous drainage to avoid early outflow restriction. This targeted devascularization transforms high-pressure malformations into manageable, soft lesions without increasing rupture risk. Ultimately, adopting targeted embolisation rather than curative intent significantly lowered the incidence of major operative complications and unfavorable patient outcomes.

Long-Term Neurofunctional Prognosis and Patient Outcomes

Beyond perioperative safety, establishing long-term functional independence remains the ultimate benchmark for neurovascular intervention. Over an extended mean follow-up of 49.90 months, the MATCH registry recorded remarkable neurofunctional preservation among patients. Severe neurological disability or death, indicated by modified Rankin Scale scores of 5 to 6, declined from 9.09% in Group 1 to 0.8% in Group 2. Additionally, long-term complete angiographic obliteration rates remained exceptionally high across the entire study population. By eliminating residual arteriovenous shunts, patients gained durable protection against recurrent hemorrhage and progressive neurological decline. Furthermore, intraoperative angiography enabled immediate detection of residual nidus, prompting instant resection before completing the initial operation. This seamless hybrid workflow eliminates the anxiety and hemorrhagic vulnerability associated with incomplete staged resections. Consequently, long-term follow-up demonstrates that combining tailored embolisation with immediate microsurgical excision delivers robust, enduring neurological recovery.

Clinical Implications for Vascular Neurosurgery in India

The conclusions of this nationwide prospective registry carry vital practical guidance for neurosurgical centers across India. As advanced tertiary institutions establish hybrid angiography suites, demand for combined neurovascular procedures is expanding rapidly. However, clinical departments must recognize that single-stage AVM surgery cannot be implemented haphazardly. Dedicated multidisciplinary teams consisting of skilled neurosurgeons, neurointerventional radiologists, and neuroanesthesiologists must train together consistently. Furthermore, centers should adopt targeted or palliative embolisation strategies rather than pursuing aggressive curative endovascular obliteration. In resource-conscious Indian healthcare settings, preventing catastrophic procedural complications directly reduces intensive care admissions and treatment expenditures. Structured mentorship programs can also bridge the 25-case learning curve safely, pairing developing teams with established neurovascular experts. Ultimately, adhering to evidence-based case progression and disciplined embolisation planning will optimize clinical safety and expand successful curative treatment for complex cerebrovascular lesions.

Frequently Asked Questions

How many cases define the learning curve in single-stage AVM surgery?

Prospective registry data demonstrate that neurosurgical teams require approximately 25 cases to achieve technical reproducibility in single-stage combined procedures. Furthermore, major complication rates and unfavorable outcomes decrease substantially after completing 50 procedures. Consequently, institutional proctorship and structured training programs remain vital during early procedural adoption to safeguard clinical outcomes.

Why is targeted embolisation preferred over curative embolisation in hybrid procedures?

Curative embolisation attempts aggressive nidus obliteration, which frequently triggers dangerous hemodynamic shifts and premature venous thrombosis. In contrast, targeted or palliative embolisation selectively occludes deep arterial feeders and aneurysms while preserving critical venous drainage. This strategic approach softens the lesion for safer microsurgical dissection without escalating perioperative hemorrhagic complications.

What infrastructure is necessary to perform single-stage AVM surgery safely?

Safe execution requires a state-of-the-art hybrid operating room equipped with advanced ceiling-mounted or robotic digital subtraction angiography. Additionally, institutions must field a synchronized multidisciplinary team comprising experienced neurosurgeons, endovascular neurointerventionalists, neuroanesthesiologists, and specialized scrub personnel capable of transitioning seamlessly between endovascular and open microsurgical phases under one general anesthetic.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Yu T et al. Learning curve and embolisation strategy in single-stage surgery combined embolisation and microsurgery for brain arteriovenous malformations: results from a nationwide multicentre prospective registry study. Stroke Vasc Neurol. 2025 Dec 23. doi: 10.1136/svn-2025-004051. PMID: 40194846.
2. Chen Y, Li R, Ma L, et al. Single-Stage Combined Embolization and Resection for Spetzler-Martin Grade III/IV/V Arteriovenous Malformations: A Single-Center Experience and Literature Review. Front Neurol. 2020;11:570198. doi: 10.3389/fneur.2020.570198.
3. Murayama Y, Arakawa H, Ishibashi T, et al. Combined surgical and endovascular treatment of complex cerebrovascular diseases in the hybrid operating room. J Neurointerv Surg. 2013;5(5):489-493. doi: 10.1136/neurintsurg-2012-010382.